Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
Chanchlani R, Thorner P, Radhakrishnan S, Hebert D, Langlois V, Arora S, Barth D, Cattran D, Kirschfink M, Licht C. Chanchlani R, et al. Among authors: kirschfink m. Kidney Int Rep. 2017 Sep 8;3(2):482-485. doi: 10.1016/j.ekir.2017.08.019. eCollection 2018 Mar. Kidney Int Rep. 2017. PMID: 29725653 Free PMC article. No abstract available.
C3 deposition glomerulopathy due to a functional factor H defect.
Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C. Habbig S, et al. Among authors: kirschfink m. Kidney Int. 2009 Jun;75(11):1230-1234. doi: 10.1038/ki.2008.354. Epub 2008 Jul 16. Kidney Int. 2009. PMID: 18633337 Free article. No abstract available.
Eculizumab and refractory membranoproliferative glomerulonephritis.
Radhakrishnan S, Lunn A, Kirschfink M, Thorner P, Hebert D, Langlois V, Pluthero F, Licht C. Radhakrishnan S, et al. Among authors: kirschfink m. N Engl J Med. 2012 Mar 22;366(12):1165-6. doi: 10.1056/NEJMc1106619. N Engl J Med. 2012. PMID: 22435384 No abstract available.
Successful treatment of DEAP-HUS with eculizumab.
Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C. Noone D, et al. Among authors: kirschfink m. Pediatr Nephrol. 2014 May;29(5):841-51. doi: 10.1007/s00467-013-2654-x. Epub 2013 Nov 20. Pediatr Nephrol. 2014. PMID: 24249282
Eculizumab hepatotoxicity in pediatric aHUS.
Hayes W, Tschumi S, Ling SC, Feber J, Kirschfink M, Licht C. Hayes W, et al. Among authors: kirschfink m. Pediatr Nephrol. 2015 May;30(5):775-81. doi: 10.1007/s00467-014-2990-5. Epub 2014 Nov 22. Pediatr Nephrol. 2015. PMID: 25416628 Free article.
MPGN II--genetically determined by defective complement regulation?
Licht C, Schlötzer-Schrehardt U, Kirschfink M, Zipfel PF, Hoppe B. Licht C, et al. Among authors: kirschfink m. Pediatr Nephrol. 2007 Jan;22(1):2-9. doi: 10.1007/s00467-006-0299-8. Epub 2006 Sep 23. Pediatr Nephrol. 2007. PMID: 17024390
199 results